Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference
Apyx Medical (NASDAQ:APYX) announced its participation in the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024, in New York. President and CEO Charlie Goodwin and CFO Matt Hill will conduct a fireside chat at 4:00pm ET and meet with investors throughout the day. The chat will be available via live webcast and replay on the company's investor relations website.
Apyx Medical specializes in advanced energy technology, particularly its Helium Plasma Platform Technology marketed as Renuvion® for cosmetic surgery and J-Plasma® for hospital surgical markets. These products provide controlled heat delivery to tissue, supported by over 90 clinical documents.
Apyx Medical (NASDAQ:APYX) ha annunciato la sua partecipazione alla 36a Conferenza Annuale sulla Sanità di Piper Sandler il 4 dicembre 2024, a New York. Il Presidente e CEO Charlie Goodwin e il CFO Matt Hill condurranno una chiacchierata informale alle 16:00 ET e incontreranno gli investitori durante tutta la giornata. La chiacchierata sarà disponibile in diretta sul webcast e in replica sul sito web per le relazioni con gli investitori dell'azienda.
Apyx Medical si specializza in tecnologia energetica avanzata, in particolare nella sua Helium Plasma Platform Technology, commercializzata come Renuvion® per la chirurgia cosmetica e J-Plasma® per i mercati chirurgici ospedalieri. Questi prodotti offrono una somministrazione controllata di calore ai tessuti, supportata da oltre 90 documenti clinici.
Apyx Medical (NASDAQ:APYX) anunció su participación en la 36ª Conferencia Anual de Atención Médica de Piper Sandler el 4 de diciembre de 2024, en Nueva York. El Presidente y CEO Charlie Goodwin y el CFO Matt Hill realizarán una charla informal a las 4:00 p.m. ET y se reunirán con los inversores durante todo el día. La charla estará disponible a través de una transmisión en vivo y su repetición en el sitio web de relaciones con inversores de la empresa.
Apyx Medical se especializa en tecnología de energía avanzada, particularmente en su Helium Plasma Platform Technology, comercializada como Renuvion® para cirugía estética y J-Plasma® para mercados quirúrgicos hospitalarios. Estos productos proporcionan una entrega de calor controlada a los tejidos, respaldada por más de 90 documentos clínicos.
Apyx Medical (NASDAQ:APYX)는 2024년 12월 4일 뉴욕에서 열리는 Piper Sandler 제36회 연례 의료 회의에 참여한다고 발표했습니다. 회장 겸 CEO인 Charlie Goodwin과 CFO인 Matt Hill은 오후 4시(ET)에 담배를 피우며 대화를 나누고 하루 종일 투자자들과 만날 예정입니다. 이번 대화는 회사의 투자자 관계 웹사이트에서 생중계 및 재생됩니다.
Apyx Medical은 특히 Renuvion®으로 판매되는 Helium Plasma Platform Technology와 병원 외과 시장을 위한 J-Plasma®에 중점을 두고 고급 에너지 기술을 전문으로 합니다. 이 제품들은 조직에 대한 열 전달을 통제할 수 있으며, 90건 이상의 임상 문서에 의해 뒷받침됩니다.
Apyx Medical (NASDAQ:APYX) a annoncé sa participation à la 36e Conférence Annuelle de Santé de Piper Sandler le 4 décembre 2024, à New York. Le Président et CEO Charlie Goodwin ainsi que le CFO Matt Hill animeront une discussion informelle à 16h00 ET et rencontreront les investisseurs tout au long de la journée. La discussion sera disponible en direct via un webcast et en replay sur le site web des relations investisseurs de l'entreprise.
Apyx Medical se spécialise dans la technologie énergétique avancée, en particulier sa Helium Plasma Platform Technology commercialisée sous le nom de Renuvion® pour la chirurgie esthétique et J-Plasma® pour les marchés chirurgicaux hospitaliers. Ces produits offrent une distribution contrôlée de chaleur aux tissus, soutenue par plus de 90 documents cliniques.
Apyx Medical (NASDAQ:APYX) gab seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler am 4. Dezember 2024 in New York bekannt. Präsident und CEO Charlie Goodwin sowie CFO Matt Hill werden um 16:00 Uhr ET ein informelles Gespräch führen und den ganzen Tag über mit Investoren zusammentreffen. Das Gespräch wird über einen Live-Stream und eine Wiederholung auf der Investor-Relations-Website des Unternehmens verfügbar sein.
Apyx Medical ist auf fortschrittliche Energietechnologie spezialisiert, insbesondere auf die Helium Plasma Platform Technology, die als Renuvion® für die kosmetische Chirurgie und J-Plasma® für den chirurgischen Krankenhausmarkt vermarktet wird. Diese Produkte bieten eine kontrollierte Wärmeabgabe an das Gewebe, unterstützt durch über 90 klinische Dokumente.
- None.
- None.
CLEARWATER, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that management will participate in the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024, in New York, NY.
Charlie Goodwin, the Company’s President and Chief Executive Officer, and Matt Hill, the Company’s Chief Financial Officer, will participate in a fireside chat on Wednesday, December 4, 2024, at 4:00pm ET and will hold one-on-one meetings with investors throughout the day. The fireside chat will be accessible via live webcast here, and a replay will be available on the Events section of Apyx Medical’s Investor Relations website at https://apyxmedical.com/investor_relations/.
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
Investor Relations Contact:
Jeremy Feffer, Managing Director LifeSci Advisors
212-915-2568
jfeffer@lifesciadvisors.com
FAQ
When is Apyx Medical (APYX) presenting at the Piper Sandler Healthcare Conference?
What products does Apyx Medical (APYX) market in the cosmetic surgery sector?
How many clinical documents support Apyx Medical's (APYX) Renuvion and J-Plasma products?
Where can investors watch Apyx Medical's (APYX) Piper Sandler Conference presentation?
